DYNE THERAPEUTICS INC's ticker is DYN and the CUSIP is 26818M108. A total of 76 filers reported holding DYNE THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $191,950 | -1.9% | 21,423 | +23.2% | 0.00% | – |
Q2 2023 | $195,660 | -13.0% | 17,392 | -10.9% | 0.00% | – |
Q1 2023 | $224,836 | +5.4% | 19,517 | +6.1% | 0.00% | – |
Q4 2022 | $213,256 | +18.5% | 18,400 | +29.7% | 0.00% | – |
Q3 2022 | $180,000 | +83.7% | 14,191 | -0.4% | 0.00% | – |
Q2 2022 | $98,000 | -37.6% | 14,249 | -12.6% | 0.00% | – |
Q1 2022 | $157,000 | -27.6% | 16,309 | -10.6% | 0.00% | – |
Q4 2021 | $217,000 | -22.8% | 18,247 | +5.6% | 0.00% | – |
Q3 2021 | $281,000 | -25.1% | 17,273 | -3.1% | 0.00% | – |
Q2 2021 | $375,000 | +151.7% | 17,830 | +85.7% | 0.00% | – |
Q1 2021 | $149,000 | -40.4% | 9,602 | -19.2% | 0.00% | – |
Q4 2020 | $250,000 | – | 11,884 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Vida Ventures Advisors, LLC | 2,960,046 | $28,535,000 | 16.60% |
MPM ASSET MANAGEMENT LLC | 4,951,303 | $47,731,000 | 16.31% |
Atlas Venture Life Science Advisors, LLC | 8,934,902 | $86,132,000 | 10.89% |
Logos Global Management LP | 2,734,392 | $26,360,000 | 3.42% |
Deep Track Capital, LP | 3,500,000 | $33,740,000 | 2.16% |
Octagon Capital Advisors LP | 525,284 | $5,064,000 | 1.10% |
HighVista Strategies LLC | 168,691 | $1,626,000 | 1.03% |
Monashee Investment Management LLC | 279,704 | $2,696,000 | 0.78% |
COMMODORE CAPITAL LP | 305,125 | $2,941,000 | 0.66% |
RA Capital Management | 2,805,045 | $27,041,000 | 0.59% |